Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moleculin Biotech, Inc. - Common Stock (NQ:MBRX)

0.4059 -0.2014 (-33.16%)
Streaming Delayed Price Updated: 11:28 AM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,691,723
Open 0.3987
Bid (Size) 0.4059 (2)
Ask (Size) 0.4060 (1)
Prev. Close 0.6073
Today's Range 0.3930 - 0.4200
52wk Range 0.2500 - 3.650
Shares Outstanding 14,000,494
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The market is filled with gapping stocks in Thursday's session.
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
US Stocks Mixed; Nvidia Posts Upbeat Earnings
 
Via Benzinga

Performance

YTD
-77.1%
-77.1%
1 Month
-26.2%
-26.2%
3 Month
-54.5%
-54.5%
6 Month
-67.8%
-67.8%
1 Year
-83.6%
-83.6%

More News

Read More
Moleculin Biotech Misses Fiscal Q2 EPS
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Gapping stocks in Tuesday's session
Via Chartmill
Top 3 Health Care Stocks You'll Regret Missing This Quarter
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-06-20: top gainers and losers in today's session.
Via Chartmill
Gold Moves Lower; Darden Restaurants Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Gapping stocks in Friday's session
Via Chartmill
Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings
Via Benzinga
Topics Stocks
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wednesday's session: gap up and gap down stocks
Via Chartmill
Moleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ Setup
Via Stocktwits
Earnings Scheduled For May 13, 2025
Via Benzinga
Earnings Scheduled For March 21, 2025
Via Benzinga
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
Via Stocktwits

Frequently Asked Questions

Is Moleculin Biotech, Inc. - Common Stock publicly traded?
Yes, Moleculin Biotech, Inc. - Common Stock is publicly traded.
What exchange does Moleculin Biotech, Inc. - Common Stock trade on?
Moleculin Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moleculin Biotech, Inc. - Common Stock?
The ticker symbol for Moleculin Biotech, Inc. - Common Stock is MBRX on the Nasdaq Stock Market
What is the current price of Moleculin Biotech, Inc. - Common Stock?
The current price of Moleculin Biotech, Inc. - Common Stock is 0.4059
When was Moleculin Biotech, Inc. - Common Stock last traded?
The last trade of Moleculin Biotech, Inc. - Common Stock was at 08/28/25 11:28 AM ET
What is the market capitalization of Moleculin Biotech, Inc. - Common Stock?
The market capitalization of Moleculin Biotech, Inc. - Common Stock is 5.68M
How many shares of Moleculin Biotech, Inc. - Common Stock are outstanding?
Moleculin Biotech, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.